相关实验视频

Updated: Jun 8, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

膀癌中的髓衍生抑制细胞:一个新兴的目标

Clément Klein^1,2,3, Samy Mebroukine^1,2,3, Mathilde Madéry^1,3

¹CNRS UMR 5164, ImmunoConcEpT, Biological and Medical Sciences Department, University of Bordeaux, 146 rue Léo Saignat, 33000 Bordeaux, France.

|November 8, 2024

概括

骨髓系衍生抑制细胞 (MDSCs) 驱动膀癌的进展和治疗耐药性. 向MDSC可能会改善免疫疗法和化疗的结果,但需要进一步的研究才能找到有效的策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
泌尿器科泌尿器科泌尿器科泌尿器科

背景情况:

膀癌是一个重大的健康问题.
骨髓系衍生抑制细胞 (MDSCs) 创造了一个免疫抑制瘤微环境.
MDSCs促进瘤生长,免疫逃避和治疗抵抗.

研究的目的:

审查MDSCs在膀癌中的作用.
探索MDSC参与免疫调节和治疗耐药性的研究.
讨论MDSC作为生物标志物和治疗点.

主要方法:

对膀癌中MDSCs研究的文献综述.
对MDSC功能在瘤进展和免疫逃避中的分析.
评估MDSC对BCG,化疗和ICI的反应中的作用.

主要成果:

MDSCs显著促进膀癌的免疫抑制.
MDSCs与抗BCG,化疗和免疫检查点抑制剂 (ICI) 的耐药性有关.
向MDSC显示了增强抗瘤免疫力的潜力.

结论:

膀癌的MDSC是膀癌病原和治疗耐药性的关键参与者.
单独或与现有疗法一起准MDSC可能会改善临床结果.
进一步的研究是必不可少的,以确定和治疗调节MDSC亚群,以优化膀癌治疗.

关键词:

生物标志物生物标志物膀癌:膀癌是一种癌症.免疫抑制免疫抑制免疫疗法免疫疗法来自骨髓细胞的抑制细胞.瘤微环境是一个微环境.

更多相关视频

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...